IL21 and neoplasm: In a direct comparison, using CAR NK cells generated from the same CB donor, mice receiving CAR-NK cells expanded with uAPC achieved better tumor control (Figures 3G,H) and survived significantly longer (Figure 3I) when compared to animals treated with CAR-NK cells generated with C9/IL-21.